Athira pharma announces upcoming poster presentation at american academy of neurology (aan) 2024 annual meeting

Presentation to highlight therapeutic potential of athira's small molecules targeting the neurotrophic hgf system in neurodegenerative disorders, including alzheimer's disease, parkinson's disease and amyotrophic lateral sclerosis presentation to highlight therapeutic potential of athira's small molecules targeting the neurotrophic hgf system in neurodegenerative disorders, including alzheimer's disease, parkinson's disease and amyotrophic lateral sclerosis
ATHA Ratings Summary
ATHA Quant Ranking